Ebere
Okpara
Seasoned health outcomes researcher advancing real-world evidence generation and market access strategy across immunology, oncology, and chronic diseases.
Passionate About Healthcare Impact
"My mission is to generate rigorous real-world evidence that improves clinical decision-making and advances health equity."
I am a pharmacist-scientist and researcher with extensive expertise in health outcomes research, pharmacoepidemiology, and market access.
Currently pursuing my PhD at the University of Illinois Chicago, I work across multiple therapeutic areas including oncology, respiratory, and cardiometabolic diseases. My research is supported by NIH and ATS grants, and I have contributed to studies that directly inform clinical, regulatory, and payer decision-making.
Areas of Expertise
Technical Skills
PhD
Health Economics and Outcomes Research
Award-Winning
Multiple national awards for research excellence
Market Access
Global strategy experience at Johnson & Johnson
Published Author
15+ peer-reviewed publications in Q1 journals
Experience & Education
Global Market Access Intern
Johnson & Johnson Innovative Medicine
Contributing to cost-effectiveness model development for immunology indications and leading HTA landscape analyses across multiple regions. Developing evidence-based messaging platforms for oncology market access policy and FDA Accelerated Approval pathways through cross-functional stakeholder engagement.
PhD Candidate & Researcher
University of Illinois Chicago
Conducting SEER-Medicare studies on comparative effectiveness and safety of cancer therapeutics. Co-Investigator on ATS-funded COPD medication adherence study and research team member for NIH-funded ACTION study improving asthma outcomes. Guest lecturer on research design, pharmacoepidemiology, and causal inference methods.
Data Scientist
Pharma Business Review
Conducted market research on hypertension medications in Sub-Saharan Africa and developed predictive models using Python and SQL for market trend forecasting. Built interactive Power BI dashboards that enhanced strategic decision-making.
Clinical Pharmacist
University College Hospital, Ibadan
Provided pharmaceutical services at Nigeria's first and premier tertiary hospital, rotating through specialized units including ICU, internal medicine, pediatrics, and surgery. Conducted medication reviews, participated in ward rounds, and collaborated with multidisciplinary teams to optimize patient outcomes.
Awards & Recognition
WOCIP Foundation We Are Pharma Distinguished Scholar
Graduate Student Excellence Award, Edward Benes Memorial Fellowship
2nd Place, Midwest Healthcare Case Competition
Top 3 Team in Americas, Think-Cell Global Case Competition
Pharmaco-Equity Conference Award, University of Pittsburgh
Student Keynote Speaker, 92nd Annual Conference, Pharmaceutical Society of Nigeria
Education
PhD, Health Outcomes Research
University of Illinois Chicago • 2022-Present
BPharm, Pharmacy
University of Nigeria • 2014-2019
Advancing Healthcare Through Evidence
Real-World Evidence
Generating actionable insights from large administrative and clinical datasets including SEER-Medicare, Truven MarketScan, and electronic health records to inform clinical and regulatory decision-making.
Healthcare & System Evaluation
Assessing healthcare interventions, treatment effectiveness, and system-level outcomes across oncology, respiratory, and cardiometabolic therapeutic areas.
Implementation Research
Investigating the adoption and integration of healthcare innovations, including AI systems in clinical settings and health technology interventions for underserved populations.
Selected Publications
View all on Google ScholarReal-world effectiveness and cardiovascular safety of abiraterone versus enzalutamide amongst older patients diagnosed with metastatic castration-resistant prostate cancer
Journal of Geriatric Oncology • 2025(4 citations)
End user experience of a widely used artificial intelligence-based sepsis system
JAMIA Open • 2024(10 citations)
Pathologic complete response in patients with esophageal cancer receiving neoadjuvant chemotherapy or chemoradiation: A systematic review and meta-analysis
Cancer Medicine • 2024(25 citations)
Physical Activity Intervention for Urban Black Women with Asthma: Protocol for a Randomized Controlled Efficacy Study
JMIR Research Protocols • 2024(1 citations)
GLP-1 Receptor Agonists vs. DPP-4 Inhibitors and SGLT2 Inhibitors on Liver Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease
Diabetes • 2025
Conference Highlights
Real-world comparative effectiveness of enzalutamide vs abiraterone
Healthcare Costs Following Lamotrigine
GLP-1 receptor agonists vs. DPP-4 inhibitors on liver outcomes
Seizure risk in metastatic castration-resistant prostate cancer
15+Peer-reviewed publications in Q1 journals
Let's Connect
I am always interested in discussing healthcare research collaborations, speaking opportunities, or connecting with fellow professionals passionate about improving health outcomes through evidence-based approaches.
Professional Affiliations
- •International Society for Pharmacoepidemiology (ISPE) - President
- •International Society for Pharmacoeconomics & Outcomes Research (ISPOR)
- •International Federation of Pharmaceutical Sciences - Steering Committee